Company Overview of Replicon Technologies, Inc.
Replicon Technologies, Inc. operates as a developer of replicons (RNA molecules that have the capacity for self-replication) and a patented procedure to encapsulate them into virus-like particles for the large-scale growth and purification required for therapeutic applications. Replicon Technologies, Inc. was founded in 1997 and is based in Birmingham, Alabama.
2800 Milan Court
Birmingham, AL 35211-6973
Founded in 1997
Key Executives for Replicon Technologies, Inc.
Replicon Technologies, Inc. does not have any Key Executives recorded.
Similar Private Companies By Industry
|CG Therapeutics, Inc.||United States|
|Zimmer Orthobiologics, Inc.||United States|
|AuraZyme Pharmaceuticals, Inc.||United States|
|ZaBeCor Pharmaceuticals, LLC||United States|
|Strategic Science & Technologies, LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Replicon Technologies, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.